Advertisement

Advertisement

LOVFF Stock Latest News

Cannara Biotech: Analyst Maintains Buy Rating and $3.00 Price Target on Growth Momentum and Shareholder-Friendly Capital Actions

RatingsCannara Biotech: Analyst Maintains Buy Rating and $3.00 Price Target on Growth Momentum and Shareholder-Friendly Capital Actions

Cannara Biotech Names New CFO to Support Growth Strategy

PremiumCompany Announcements

Cannara Biotech Names New CFO to Support Growth Strategy

29d ago

Cannara Biotech price target raised to C$4 from C$3.25 at TD Securities

PremiumThe Fly

Cannara Biotech price target raised to C$4 from C$3.25 at TD Securities

3M ago

Source Rock Royalties Declares Monthly Dividend and Grants RSUs to Leadership

PremiumCompany Announcements

Source Rock Royalties Declares Monthly Dividend and Grants RSUs to Leadership

3M ago

Cannara Biotech: Buy Rating Reiterated on Strong Q3 Beat, Operational Expansion, and $3.00 Price Target

PremiumRatings

Cannara Biotech: Buy Rating Reiterated on Strong Q3 Beat, Operational Expansion, and $3.00 Price Target

3M ago

Cannara Biotech Earnings Call Highlights Growth and Expansion

PremiumCompany AnnouncementsCannara Biotech Earnings Call Highlights Growth and Expansion

3M ago

LOVFF Upcoming Earnings Report: What to Expect?

Pre-Earnings

LOVFF Upcoming Earnings Report: What to Expect?

3M ago

Cannara Biotech Posts Solid Q2, Becomes Top Cannabis Retailer in Québec

Company Announcements

Cannara Biotech Posts Solid Q2, Becomes Top Cannabis Retailer in Québec

6M ago

Cannara Biotech Sets Date for Q2 2026 Results as Haywood Securities Initiates Coverage

PremiumCompany Announcements

Cannara Biotech Sets Date for Q2 2026 Results as Haywood Securities Initiates Coverage

6M ago

Cannara Biotech Wins TSX Listing and TD Cowen Coverage

PremiumCompany Announcements

Cannara Biotech Wins TSX Listing and TD Cowen Coverage

7M ago

Cannara Biotech to Uplist Shares to Toronto Stock Exchange

PremiumCompany Announcements

Cannara Biotech to Uplist Shares to Toronto Stock Exchange

7M ago

Cannara Biotech graduates to TSX

PremiumThe Fly

Cannara Biotech graduates to TSX

7M ago

Cannara Biotech initiated with a Buy at TD Securities

PremiumThe FlyCannara Biotech initiated with a Buy at TD Securities

7M ago

Cannara Biotech Schedules Investor Webcast to Highlight Cannabis Operations

Company Announcements

Cannara Biotech Schedules Investor Webcast to Highlight Cannabis Operations

8M ago

Cannara Biotech Secures C$6.3 Million Premium Private Placement from Phoenician Capital

Company Announcements

Cannara Biotech Secures C$6.3 Million Premium Private Placement from Phoenician Capital

8M ago

Cannara Biotech prices 3M shares at C$2.10 in private placement

PremiumThe Fly

Cannara Biotech prices 3M shares at C$2.10 in private placement

8M ago

Cannara Biotech Secures Conditional TSX Approval in Strategic Uplisting Move

PremiumCompany Announcements

Cannara Biotech Secures Conditional TSX Approval in Strategic Uplisting Move

8M ago

Cannara Biotech announces conditional approval to list on TSX

PremiumThe Fly

Cannara Biotech announces conditional approval to list on TSX

8M ago

Cannara Biotech Posts Record Q1 2026 Results and Expands Canadian Cannabis Market Share

PremiumCompany Announcements

Cannara Biotech Posts Record Q1 2026 Results and Expands Canadian Cannabis Market Share

8M ago

Cannara Biotech reports Q1 EPS C$0.01 vs. C$0.03 last year

PremiumThe FlyCannara Biotech reports Q1 EPS C$0.01 vs. C$0.03 last year

8M ago

Cannara Biotech Upgrades to OTCQX and Sets Dates for Q1 Results and Shareholder Meeting

Company Announcements

Cannara Biotech Upgrades to OTCQX and Sets Dates for Q1 Results and Shareholder Meeting

9M ago

Cannara Biotech achieves OTCQX qualification

The Fly

Cannara Biotech achieves OTCQX qualification

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >